Chronic Obstructive Pulmonary Disease

References

Alfageme I, Vazquez R, et al. Clinical efficacy of anti-pneumococcal vaccination in patients with COPD. Thorax. 2006 Mar;61(3):189-95. Epub 2005 Oct 14.

Ansaldi F, Turello V, et al. Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study. J Int Med Res. 2005 Sep-Oct;33(5):490-500.

Beckerman M, Magadle R, et al. The effects of 1 year of specific inspiratory muscle training in patients with COPD. Chest. 2005 Nov;128(5):3177-82.

Bernkop-Schnurch A, Giovanelli R, et al. Peroral administration of enzymes: Strategies to improve the galenic of dosage forms for trypsin and bromelain. Drug Dev Ind Pharm. 2000 Feb;26(2):115–21.

Borghi-Silva A, Baldissera V, et al. L-carnitine as an ergogenic aid for patients with chronic obstructive pulmonary disease submitted to whole-body and respiratory muscle training programs. Braz J Med Biol Res. 2006 Apr;39(4):465–74.

Brochard L. Mechanical ventilation: invasive versus noninvasive. Eur Respir J Suppl. 2003 Nov;47:31s-37s.

Business Wire. Weak Late Stage Pipeline Leaves Innovation to Phase I/II Candidates. Business Wire. August 2004. http://www.findarticles.com/p/articles/mi_m0EIN/is_2004_August_2/ai_n6136679. Accessed May 19, 2006.

Calverley PM. Effect of corticosteroids on exacerbations of asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2004;1(3):161-6.

Chapkin RS, Hong MY, et al. Dietary n-3 PUFA alter colonocyte mitochondrial membrane composition and function. Lipids. 2002 Feb;37(2):193–9.

Chorostowska-Wynimko J. [The beta2-adrenergic receptor agonists in the treatment of chronic obstructive pulmonary disease]. Przegl Lek. 2005;62(7):724-8.

Cornuz J. Treating tobacco use and dependence in clinical practice. Expert Opin Pharmacother. 2006 Apr;7(6):783-92.

Daga MK, Chhabra R, et al. Effects of exogenous vitamin E supplementation on the levels of oxidants and antioxidants in chronic obstructive pulmonary disease. J Biosciences. February 2003;28(1):7–11.

Drost EM, Skwarski KM, et al. Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax. 2005 Apr;60(4):293–300.

Ergas D, Eilat E, et al. N-3 fatty acids and the immune system in autoimmunity. Isr Med Assoc J. 2002 Jan;4(1):34–8.

Fernandes G, Chandrasekar B, et al. Modulation of antioxidant enzymes and programmed cell death by n-3 fatty acids. Lipids. 1996;31 Suppl:S91–S96.

Fujimoto S, Kurihara N, et al. Effects of coenzyme Q10 administration on pulmonary function and exercise performance in patients with chronic lung diseases. Clin Investig. 1993;71(8 Suppl):S162–S166.

Garrod R, Dallimore K, et al. An evaluation of the acute impact of pursed lips breathing on walking distance in nonspontaneous pursed lips breathing chronic obstructive pulmonary disease patients. Chron Respir Dis. 2005;2(2):67-72.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease Executive Summary 2004. http://www.guideline.gov/summary/summary.aspx?doc_id=8128. Accessed May 19, 2006.

Hind M, Maden M. Retinoic acid induces alveolar regeneration in the adult mouse lung. Eur Respir J. 2004 Jan;23(1):20–7.

Jaber R. Respiratory and allergic diseases: from upper respiratory tract infections to asthma. Prim Care. 2002 Jun;29(2):231-61. Review.

Kasper DL, Braunwald E, et al. Harrison's Principles of Internal Medicine. 16th ed. New York: McGraw-Hill Medical Publishing Division; 2005.

Kelly FJ. Vitamins and respiratory disease: Antioxidant micronutrients in pulmonary health and disease. Proc Nutr Soc. 2005 Nov;64(4):510–26.

Kluchova Z, Petrasova D, et al. The association between oxidative stress and obstructive lung impairment in patients with COPD. Physiol Res. 2006 Feb 23.

Koumis T, Samuel S. Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease. Clin Ther. 2005 Apr;27(4):377-92.

Lee P, Gildea TR, et al. Emphysema in nonsmokers: alpha 1-antitrypsin deficiency and other causes. Cleve Clin J Med. 2002 Dec;69(12):928-9, 933, 936 passim.

Lim TK. Treatment of severe exacerbation of chronic obstructive pulmonary disease with mask-applied continuous positive airway pressure. Respirology. 1996 Sep;1(3):189-93.

Maden M, Hind M. Retinoic acid in alveolar development, maintenance and regeneration. Philos Trans R Soc Lond B Biol Sci. 2004 May 29;359(1445):799–808.

Mao JT, Goldin JG, et al. A pilot study of all-trans-retinoic acid for the treatment of human emphysema. Am J Respir Crit Care Med. 2002 Mar 1;165(5):718–23.

Mao JT, Tashkin DP, et al. All-trans retinoic acid modulates the balance of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with emphysema. Chest. 2003 Nov;124(5):1724–32.

Matsuyama W, Mitsuyama H, et al. Effects of omega-3 polyunsaturated fatty acids on inflammatory markers in COPD. Chest. 2005 Dec;128(6):3817-27.

Meyers DA, Larj MJ, et al. Genetics of asthma and COPD. Similar results for different phenotypes. Chest. 2004 Aug;126(2 Suppl):105S-110S; discussion 159S-161S. Review.

Nadeem A, Raj HG, et al. Increased oxidative stress and altered levels of antioxidants in chronic obstructive pulmonary disease. Inflammation. 2005 Feb;29(1):23–32.

Paiva SA, Goldoy I, et al. Assessment of vitamin A status in chronic obstructive pulmonary disease patients and healthy smokers. Am J Clin Nutr. 1996 Dec;64(6):928–34.

Pierson DJ. Clinical practice guidelines for chronic obstructive pulmonary disease: a review and comparison of current resources. Respir Care. 2006 Mar;51(3):277-88.

Rahman I, Biswas RK, et al. Oxidant and antioxidant balance in the airways and airway diseases. Eur J Pharmacol. 2006 Mar 8;533(1-3):222–39.

Romieu I, Trenga C. Diet and obstructive lung diseases. Epidemiol Rev. 2001;23(2):268–87.

Schols A. Nutritional modulation as part of the integrated management of chronic obstructive pulmonary disease. Proc Nutr Soc. 2003 Nov;62(4):783–91.

Shahar E, Folsom AR, et al. Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease. Atherosclerosis Risk in Communities Study Investigators. N Engl J Med. 1994 Jul 28;331(4):228-33.

Spurzem JR, Rennard SI. Pathogenesis of COPD. Semin Respir Crit Care Med. 2005 Apr;26(2):142–53.

Stey C, Steurer J, et al. The effect of oral N-acetylcysteine in chronic bronchitis: A quantitative systematic review. Eur Resp J. 2000 Aug;16(2):253–62.

Sutherland ER, Cherniack RM. Management of chronic obstructive pulmonary disease. N Engl J Med. 2004 Jun 24;350(26):2689-97.

Tug T, Karatas F, et al. Antioxidant vitamins (A,C, and E) and malondialdehyde levels in acute exacerbation and stable periods of patients with chronic obstructive pulmonary disease. Clin & Inv Med. June 2004;27(3):123–8.

Urbano FL, Pascual RM. Contemporary issues in the care of patients with chronic obstructive pulmonary disease. J Manag Care Pharm. 2005 Jun;11(5 Suppl A):S2-13; quiz S14-6.

US National Library of Medicine. Genetics Home Reference: Alpha-1 antitrypsin deficiency 2005. Available at: www.ghr.nlm.nih.gov/condition=alpha1antitrypsindeficiency. Accessed May 15, 2006

van Helvoort HA, Heijdra YF, et al. Supplemental Oxygen Prevents Exercise-induced Oxidative Stress in Muscle-wasted Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2006 May 15;173(10):1122-9. Epub 2006 Mar 2.

Vignola AM. PDE4 inhibitors in COPD: A more selective approach to treatment. Resp Med. June 2004;98(6):495–503.

Weder MM, Donohue JF. Role of bronchodilators in chronic obstructive pulmonary disease. Semin Respir Crit Care Med. 2005 Apr;26(2):221-34.

Wijkstra PJ. Home based rehabilitation for patients with COPD. Is it equally effective as compared to outpatient rehabilitation? Monaldi Arch Chest Dis. 2003 Oct-Dec;59(4):335-7.

Zwick H, Lichtenschopf A. [COPD-rehabilitation]. Wien Med Wochenschr. 2005 Mar;155(5-6):101-5.